Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
Signature Care Hemorrhoidal cocoa butter, phenylephrine HCl 2211 mg; 6.5 mg Suppository, 12 suppositories — NDC 21130-628-53 (Billing 21130-0628-53)
by Safeway · 12 BLISTER PACK in 1 CARTON / 1 SUPPOSITORY in 1 BLISTER PACK
This is a package of 12 suppositories of Signature Care Hemorrhoidal cocoa butter, phenylephrine HCl 2211 mg; 6.5 mg Suppository from Safeway, no longer marketed (first marketed Nov 2015), no longer in the FDA NDC Directory. It is the main listing for this product, which comes in 2 package sizes.
NDC 21130-0628-53
🏷️ FDA NDC (as labeled)
21130-628-53
billing pads the product segment with a zero
This package
Contains12 suppositories
Pack sizes2 compare ↓
Main listing for product 21130-628 · Also comes in:
24 suppositories 21130-628-62
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
NDC database record
One package, one record: these facts belong to NDC 21130-628-53 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 21130 labeler · 628 product · 53 package
- Listing certified through
- Dec 31, 2026
- Barcode (UPC-A, from the NDC)
- 3 2113062853 8
- FDA record last changed
- Jul 24, 2026
⚠️
Excluded from the active FDA NDC Directory.
The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory.
Search the FDA NDC Directory ↗
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
21130-628-53
Product NDC
21130-628
11-digit billing NDC
21130062853
RxCUI
1438497
UNII
512OYT1CRR, 04JA59TNSJ
Application #
M015
SPL Set ID
e74b71a1-915d-4e5b-b548-d5cce7945dbd
Established class (EPC)
alpha-1 Adrenergic Agonist
Mechanism of action
Adrenergic alpha1-Agonists
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
Discontinued
FDA listing status
Discontinued by firm
Marketing start
2015-11-03
Route
RECTAL
Dosage form
SUPPOSITORY
Substance
COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE
Quick answers
- RxCUI (RxNorm): 1438497
Why two NDCs?
The FDA registers this code as 21130-628-53 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 21130-0628-53. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 3, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
Clinical
🧪 What is this product?
This is an over-the-counter hemorrhoidal suppository marketed under FDA's monograph rules for this product category. It contains cocoa butter, a lubricating and soothing base ingredient commonly used in rectal products, and phenylephrine hydrochloride, a decongestant typically used to reduce swelling and shrink blood vessels in the affected area. The suppository is inserted rectally and is intended for temporary relief of hemorrhoid-related discomfort.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 3, 2026
💬 Questions about cocoa butter, phenylephrine HCl?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size:
24 suppositories
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 4, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 21130-0628-53 You're viewing this Main listing | 12 BLISTER PACK in 1 CARTON / 1 SUPPOSITORY in 1 BLISTER PACK | 2015-11-03 | — | Discontinued by firm |
| 21130-0628-62 21130-628-62 | 24 BLISTER PACK in 1 CARTON / 1 SUPPOSITORY in 1 BLISTER PACK | 2015-11-03 | — | Active |
Pack size FAQ
What quantity is in this package?
This package contains 12 suppositories — 12 blister pack in 1 carton / 1 suppository in 1 blister pack.
How does this package differ from NDC 21130-0628-62?
Both are Signature Care Hemorrhoidal cocoa butter, phenylephrine HCl 2211 mg; 6.5 mg Suppository — the drug itself is identical. This page's package is the 12 suppositories one, while NDC 21130-0628-62 is the 24 suppositories package.
What NDC number is used to bill for this package of Signature Care Hemorrhoidal cocoa butter, phenylephrine HCl 2211 mg; 6.5 mg Suppository?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Good Sense Hemorrhoidal 2211 mg/1; 6.5 mg 00113-0279-53 | L. | 12 suppositories | $0.288 | — | Availability likely | — |
| rugby hemorrhoidal 2211 mg/1; 6.5 mg 00536-1186-12 | Rugby | 12 suppositories | $0.288 | — | Availability likely | — |
| Hemorrhoidal 2.39 g/1; 6.75 mg 46122-0777-65 | Amerisourcebergen | 12 suppositories | $0.288 | — | Availability likely | — |
| Leader Hemorrhoidal 2211 mg/1; 6.5 mg 70000-0223-01 | Cardinal | 12 suppositories | $0.288 | — | Availability likely | — |
| foster and thrive hemorrhoidal 2211 mg/1; 6.5 mg 70677-1292-01 | Strategic | 12 suppositories | $0.288 | — | Availability likely | — |
| Walgreens Hemorrhoidal 2211 mg/1; 6.25 mg 00363-0476-24 | Walgreens | 24 suppositories | — | — | FDA listed | — |
| Preparation H 00573-2884-12 | Haleon | 12 suppositories | — | — | FDA listed | — |
| hemorrhoidal relief 2211 mg/1; 6.5 mg 11822-0005-01 | Rite | 12 suppositories | — | — | FDA listed | — |
| Hemorrhoidal cocoa butter 2.5 mg/g; 884.4 mg/g 13709-0323-01 | NeilMed | 24 capsules | — | — | FDA listed | — |
| Signature Care Hemorrhoidal 2211 mg/1; 6.5 mgthis 21130-0628-53 | Safeway | 12 suppositories | — | — | Discontinued | — |
| hemorrhoidal 2211 mg/1; 6.5 mg 30142-0279-62 | Kroger | 24 suppositories | — | — | FDA listed | — |
| topcare hemorrhoidal 2211 mg/1; 6.5 mg 36800-0279-53 | Topco | 12 suppositories | — | — | FDA listed | — |
| hemorrhoidal 2211 mg/1; 6.5 mg 37808-0279-62 | H | 24 suppositories | — | — | FDA listed | — |
| Equaline Hemorrhoidal 2211 mg/1; 6.5 mg 41163-0279-53 | United | 12 suppositories | — | — | FDA listed | — |
| hemorrhoidal 2211 mg/1; 6.5 mg 41250-0279-62 | Meijer | 24 suppositories | — | — | FDA listed | — |
| hemorrhoidal 2211 mg/1; 6.5 mg 42507-0279-53 | HyVee | 12 suppositories | — | — | FDA listed | — |
| equate hemorrhoidal 2211 mg/1; 6.5 mg 49035-0463-62 | Wal-Mart | 24 suppositories | — | — | FDA listed | — |
| Exchange Select Hemorrhoidal 2211 mg/1; 6.5 mg 55301-0279-62 | Army | 24 suppositories | — | — | FDA listed | — |
| rexall hemorrhoidal 2211 mg/1; 6.5 mg 55910-0279-53 | Dolgencorp | 12 suppositories | — | — | FDA listed | — |
| hemorrhoidal 2211 mg/1; 6.5 mg 56062-0279-53 | Publix | 12 suppositories | — | — | FDA listed | — |
| Xyralid Hemorrhoidal 88.5 g/100g; .26 g/100g 57483-0410-13 | Innovus | 24 g | — | — | FDA listed | — |
| hemorrhoidal 2211 mg/1; 6.5 mg 59779-0279-53 | CVS | 12 suppositories | — | — | FDA listed | — |
| Hemorrhoidal 1768.8 mg/1; 5 mg 70795-1021-02 | GRAXCELL | 12 suppositories | — | — | FDA listed | — |
| basic care hemorrhoidal 2211 mg/1; 6.5 mg 72288-0800-62 | Amazon.com | 24 suppositories | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
🏛️
2015
On the market since
Nov 2015
📍
2026
Currently FDA-listed
11 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Oct 3, 2026
What it looks like
Color
Yellow
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
- FDA label on DailyMed · label index refreshed Oct 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII A2I8C7HI9T
Methylparaben is a preservative derived from benzoic acid that prevents growth of bacteria, fungi, and mold in medicines. It extends the product's shelf life and maintains safety during storage.
-
UNII Z8IX2SC1OH
Propylparaben is a chemical preservative used to prevent bacterial and fungal growth in medicines and personal care products. It helps extend shelf life and maintain product safety during storage.
-
UNII O8232NY3SJ
A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
3 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesmethylparaben, propylparaben, topical starch
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 3, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerSafeway
FDA applicationM015 (OTC MONOGRAPH DRUG)
Labeler code21130
First marketedNov 2015
Product typeHuman Otc Drug
Portfolio159 products on file
More NDCs from Safeway labeler code 21130
- Acid Reducer Complete famotidine, calcium carbonate and magnesium hydroxide 10 mg; 800 mg; 165 mg Tablet, Chewable NDC 21130-614-63
- Severe Sinus Congestion and Pain Maximum Strength Acetaminophen, Guaifenesin, Phenylephrine HCl 325 mg; 200 mg; 5 mg Tablet, Film Coated NDC 21130-615-09
- 4x Medicated Gum Cream Benzocaine .13 g/100g; .25 g/100g; 20 g/100g; .15 g/100g Cream NDC 21130-621-19
- Ibuprofen PM diphenhydramine citrate, 38 mg; 200 mg Tablet, Film Coated NDC 21130-623-76
- Stomach Relief Regular Strength Bismuth subsalicylate 525 mg/30mL Liquid NDC 21130-624-08
- Sinus PE Head Congestion and Mucus Acetaminophen, Guaifenesin, Phenylephrine HCl 325 mg; 200 mg; 5 mg Tablet, Film Coated NDC 21130-627-08
- Antacid Plus aluminum hydroxide, magnesium hydroxide, dimethicone 400 mg/10mL; 400 mg/10mL; 40 mg/10mL Liquid NDC 21130-629-12
- Nicotine 4 mg Lozenge NDC 21130-636-05
- CLEARLAX Polyethylene Glycol 3350 3350 17 g/17g Powder, For Solution NDC 21130-637-02
- Naproxen Sodium PM diphenhydramine hydrochloride, 25 mg; 220 mg Tablet, Film Coated NDC 21130-639-71
- Cetirizine Hydrochloride 10 mg Tablet NDC 21130-640-03
- signature care allergy relief d cetirizine hydrochloride, pseudoephedrine hydrochloride 5 mg; 120 mg Tablet, Film Coated, Extended Release NDC 21130-644-62
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
📄 Ask a Doctor Before Use If
📄 Ask a Doctor or Pharmacist Before Use If
📄 When Using This Product
📄 Stop Use and Ask a Doctor If
🤰 If Pregnant or Breast-Feeding
📄 Keep Out of Reach of Children
📄 Questions or Comments
📄 Package Label / Principal Display Panel
🎯 Indications and Usage ▾
Uses • helps relieve the local itching and discomfort associated with hemorrhoids • temporarily relieves burning and shrinks hemorrhoidal tissue • temporarily provides a coating for relief of anorectal discomforts • temporarily protects the inflamed, irritated anorectal surface to help make bowel movements less painful
⏱️ Dosage and Administration ▾
Directions • adults: when practical, cleanse the affected area by patting or blotting with an appropriate cleansing wipe. Gently dry by patting or blotting with a tissue or a soft cloth before insertion of this product. • detach one suppository from the strip; remove the foil wrapper before inserting into the rectum as follows: • hold suppository with rounded end up • see illustrations: carefully separate foil tabs by inserting tip of fingernail at end marked “peel down” • slowly and evenly peel apart (do not tear) foil by pulling tabs down both sides, to expose the suppository • remove exposed suppository from wrapper • insert one suppository into the rectum up to 4 times daily, especially at night, in the morning or after each bowel movement • children under 12 years of age: ask a doctor Other information • store at 20-25°C (68-77°F)
⚠️ Warnings ▾
Warnings For rectal use only Ask a doctor before use if you have • heart disease • high blood pressure • thyroid disease • diabetes • difficulty in urination due to enlargement of the prostate gland Ask a doctor or pharmacist before use if you are presently taking a prescription drug for high blood pressure or depression. When using this product do not exceed the recommended daily dosage unless directed by a doctor Stop use and ask a doctor if • bleeding occurs • condition worsens or does not improve within 7 days If pregnant or breast feeding, ask a health professional before use.
📦 Storage and Handling ▾
Other information • store at 20-25°C (68-77°F)
🧪 Active Ingredient ▾
Active ingredients (in each suppository) Cocoa butter 88.44% Phenylephrine HCl 0.25%
🧪 Inactive Ingredients ▾
Inactive ingredients methylparaben, propylparaben, topical starch Questions or comments? 1-888-723-3929
🎯 Purpose ▾
Purposes Protectant Vasoconstrictor
📄 Ask a Doctor Before Use If ▾
Ask a doctor before use if you have • heart disease • high blood pressure • thyroid disease • diabetes • difficulty in urination due to enlargement of the prostate gland
📄 Ask a Doctor or Pharmacist Before Use If ▾
Ask a doctor or pharmacist before use if you are presently taking a prescription drug for high blood pressure or depression.
📄 When Using This Product ▾
When using this product do not exceed the recommended daily dosage unless directed by a doctor
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if • bleeding occurs • condition worsens or does not improve within 7 days
🤰 If Pregnant or Breast-Feeding ▾
If pregnant or breast feeding, ask a health professional before use.
📄 Keep Out of Reach of Children ▾
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
📄 Questions or Comments ▾
Questions or comments? 1-888-723-3929
📄 Package Label / Principal Display Panel ▾
Package/Label Principal Display Panel Compare to Preparation H® Hemorrhoidal Suppositories active ingredients Quality Guaranteed Hemorrhoidal Suppositories COCOA BUTTER, PHENYLEPHRINE HCl Prompt soothing relief from painful burning, itching and discomfort Helps shrink swelling of irritated hemorrhoidal tissues Protects irritated tissue Also for nighttime relief 12 SUPPOSITORIES 279LJ-hemorrhoidal.jpg
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
About this NDC listing & data coverage
Over-the-counter (OTC) product
No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 24 suppositories (21130-0628-62). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Safeway is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.